Aprea Therapeutics Hosts Virtual Panel on WEE1 Inhibition in Precision Oncology
Aprea Therapeutics will host a virtual panel on WEE1 inhibition in precision oncology on Oct. 20, 2026, at 11 a.m. ET. The pre-ESMO Congress panel will examine WEE1 biology, inhibitor selectivity challenges and the clinical outlook. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative